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1. Introduction 
Butyric acid (BA) has been shown to affect many 
cellular activities [ 11, including changes in the expres- 
sion of genes [2], modifications in enzyme action [3] 
and alterations to cellular morphology [4]. The effects 
depend on the cell-type being investigated, but in all 
cases the extent of acetylation of histones is altered 
and DNA synthesis is inhibited 15-71. It has been 
suggested that these changes are not linked to the 
increased expression of certain differentiated cell 
functions [6-91. Here we have investigated the way 
in which BA enhances the yield of an inducible pro- 
tein, interferon ([ 10,l l] Johnston, personal commu- 
nication). 
2. Materials and methods 
Namalwa cells were cultured, induced and the 
interferon was assayed on MDBK cells as in [ 121 and 
the titre expressed in reference research units. When 
cells were pretreated with BA they were transferred 
to medium containing the appropriate concentration 
of BA and 2% calf serum at 2 X 106/ml 48 h before 
induction. Fractionation of the cells and the subse- 
quent RNA extractions were carried out as in [ 131. 
RNA was microinjected into oocytes at 5 mg/ml and 
the interferon produced assayed [ 141. 
3. Results 
Namalwa cells were treated for 48 h with 1 mM 
BA, induced with Sendai virus, and the rate of accu- 
mulation of interferon in the medium was compared 
lilsc,l’ic,r/Nortlr-llolland Biomedical Press 
with that from untreated cells. Fig.la shows that the 
interferon from both treated and untreated cells was 
produced over the same time period, but that the 
yield was increased -S-fold at all times. RNA was 
extracted from these cells at different times after 
induction, microinjected into oocytes and the resul- 
tant interferon titres measured. The amount of inter- 
feron mRNA in both treated and untreated cells rose 
in parallel to a maximum at 10 h post-induction, sub- 
sequently decreasing together (fig. 1 b). No difference 
in the rate at which the interferon mRNA decayed in 
the treated and untreated Namalwa cells was observed 
suggesting that its half-life was unaltered. Thus at all 
times the specific activity of interferon mRNA was 
5-fold greater in RNA extracted from treated cells 
than from control cells. This result could have been 
due to the RNA from BA-treated cells behaving dif- 
ferently from RNA from control cells in the oocyte 
assay. However measurement of the rate of synthesis 
of interferon in oocytes after microinjection of RNA 
from either treated or untreated cells showed that 
neither the stability of the mRNA in the oocyte nor 
the rate of secretion of interferon from the oocytes 
(fig.2) was changed. Therefore the increased levels of 
interferon mRNA detected by translation in oocytes 
is a reflection of enhanced levels of this mRNA in 
BA-treated Namalwa cells. 
The increase in interferon titres in the incubation 
medium of Namalwa cells treated with BA was accom- 
panied by an increase in interferon found in the cells 
homogenates and on the polysomes (table 1). Thus 
the BA treatment was not enhancing the secretion of 
interferon from the Namalwa cells. 
The increase in concentration of interferon mRNA 
was not just found in the total RNA but also in the 
cytoplasmic RNA and polysomal RNA (table l), 
203 
Volume 112, number 2 FEBS LETTERS April 1980 
2 4 
\ 
.Z 
c 
3 
: 3 L 
2 L 
0 
2 .- 
0 
2 
oi- 
0 - 
1 
A---- 
A----A 
/ 
A' 
A 
10 15 5 10 15 
time post inductton (h) 
z 
150 2. 
” 
0 
0 
0 
. 
100 .; 
3 
,’ 
; 
L 
aI 
50 .E 
Fig.1. (a) Shows the accumulated yields of interferon in cells pretreated with BA (A-A) or in control cells treated identically 
(A-a). RNA was extracted from these cells. (lb) Shows the interferon secreted from oocytes 24 h after microinjection with 
RNA (5 mg/ml) from cells pretreated with BA (A--A) or control cells (a---a). 
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Fig.2. RNA was extracted from untreated and BA-treated 
Namalwa cells 9 h after induction, injected into oocytes and 
the interferon measured after different times of incubation. 
The interferon yields present (i) in oocytes injected with 
RNA from untreated cells (o---o), their incubation medium 
(A-A) or (ii) in oocytes injected with RNA from BA- 
treated cells (g---m) or their incubation medium are shown 
(A--A). 
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although the yield of polysomes was lower from BA- 
treated cells because they are more difficult to lyse 
(A. M., unpublished). Therefore the enhanced yields 
of interferon produced by BA-treated cells were not 
caused by a higher proportion of interferon mRNA 
being recruited onto the polysomes, but by a general 
increase in the level of the interferon mRNA. 
When the poly(A’) RNA was isolated from the 
total RNA, the specific activity of interferon mRNA 
was found to be .5-fold higher in the RNA from treated 
cells. Thus BA-treatment did not cause a rise in the 
total amount of poly(A’) RNA because the amount 
of RNA binding to oligo(dT) cellulose did not alter 
(2.3% of total RNA from untreated cells and 2.4% of 
total RNA from treated cells, both values means of 4 
determinations). Neither was the mRNA from treated 
cells more active in a cell-free system because its abil- 
ity to stimulate the mRNA-dependent reticulocyte 
lysate protein synthesising system [ 151 was the same 
as the mRNA from untreated cells. Thus, these results 
show that the increase in specific activity of interferon 
Volume 112, number 2 FEBS LETTERS 
Table f 
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Interferon formed by Namalwa cells: 
in medium (un~t/m~/lO’ cells) 
in homogenate (unit/l@” cells) 
on poiysomes (unit/l 0 ii & 
5623 31622 5.6: 1 
3.2 6.4 5.3:1 
64 257 4.0: I 
Interferon formed by microinjection 
of RNA into oocytes: 
total RNA (unit/l0 oocytes) 
cytoplasm& RNA funit/lO oocytes) 
~o~ysom~ RNA (unit/l 0 oocytes) 
40 156 3.9:1 
40 200 5.O:l 
80 390 4.9:1 
Control BA-treated Ratio 
mRNA from treated cells is not due to a general 
increase in the level of mRNA or its activity. 
Finally, the effect of varying the concentration of 
BA on the interferon yields of Namafwa cells and on 
the specific activity of interferon mRNA was investi- 
1 2 
mM B.A. 
Fig.3. Cells were pretreated with varying concentrations of 
BA, induced and the RNA extracted 9 h after induction as in 
fig.1. The interferon ~~es~rodn~d (i) by untreated Namalwa 
cetis (A-A) was 5018 unit/ml, or (ii) by oocytes 24 h after 
microinjection with RNA from untreated ceils were 64 unit/ 
10 oocytes from homogenised oocytes (.----9) or 32 unit/ 
10 oocytes secreted from the oocytes (c-o). 
gated. Fig.3 shows that the enhancement of yield in 
tissue culture correlates exactly with the increase in 
the amount of interferon mRNA. This was true 
whether the interferon inside the oocytes or the 
material that they had secreted was measured. There- 
fore the BA-treatment of Namalwa cells leads to an 
increased production of interferon because the specif- 
ic activity of the interferon mRNA has risen by an 
amount sufficient to account for it. 
4. Discussion 
We have shown that treatment of Namalwa cells 
with BA increases interferon yields when they are 
subsequently induced, and that the concentration of 
interferon mRNA is greater in treated than in untreated 
cells, by an amount sufficient to account for the 
enhanced yields. 
The system described here for increasing interferon 
yields using pretreatment of cells with BA can be 
compared with the superinduction system [ 161. When 
cells are superinduced, the interferon mRNA concen- 
tration is also increased, but that increase is caused 
by an increase in the half-life of the interferon mRNA 
[ 171, Thus synthesis of interferon is prolonged and it 
appears that this accounts for the enhanced yields. In 
contrast, cells treated with BA did not synthesise 
interferon for longer than control cells, indicating that 
the half-life of the interferon mRNA was unaltered. 
Instead an increase in the specific activity of inter- 
feron mRNA was found, suggesting that the transcrip- 
tion or processing (or both) of the interferon mRNA 
was enhanced in treated cells. 
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